Psychiatry and Mental Health - MedEd On The Go

Episodes 17-32 of 35

Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
MinuteCE®
Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
1.00 program credit
- Bianca Weinstock-Guttman, MD
1.00 program credit
The Role of S1P Receptor Agonists in MS: Strategies for Disease Management
The Role of S1P Receptor Agonists in MS: Strategies for Disease Management
MinuteCE®
The Role of S1P Receptor Agonists in MS: Strategies for Disease Management
1.00 program credit
- Bianca Weinstock-Guttman, MD
1.00 program credit
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
MinuteCE®
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
1.00 program credit
- Bianca Weinstock-Guttman, MD
1.00 program credit
MinuteCE®
Multiple Sclerosis: Using S1P Receptor Modulators to Slow Disease Progression
1.00 credit 8 episodes
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Bianca Weinstock-Guttman, MD
1.00 credit 8 episodes
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
MinuteCE®
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
1.00 program credit
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
MinuteCE®
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
1.00 program credit
Who’s on First: Accurate Recognition of Schizophrenia Candidates That Would Benefit From LAI Antipsychotic Therapy
Who’s on First: Accurate Recognition of Schizophrenia Candidates That Would Benefit From LAI Antipsychotic Therapy
MinuteCE®
Who’s on First: Accurate Recognition of Schizophrenia Candidates That Would Benefit From LAI Antipsychotic Therapy
0.75 program credits
- Leslie Citrome, MD, MPH
0.75 program credits
Identifying and Managing Nonadherence to Antipsychotics in People with Schizophrenia
Identifying and Managing Nonadherence to Antipsychotics in People with Schizophrenia
MinuteCE®
Identifying and Managing Nonadherence to Antipsychotics in People with Schizophrenia
0.75 program credits
- Christoph U. Correll, MD
- Leslie Citrome, MD, MPH
0.75 program credits
Too Soon Is Not Soon Enough: Initiation of LAIs Sooner to Manage Symptoms of Suboptimally Treated Schizophrenia
Too Soon Is Not Soon Enough: Initiation of LAIs Sooner to Manage Symptoms of Suboptimally Treated Schizophrenia
MinuteCE®
Too Soon Is Not Soon Enough: Initiation of LAIs Sooner to Manage Symptoms of Suboptimally Treated Schizophrenia
0.75 program credits
- Christoph U. Correll, MD
0.75 program credits
MinuteCE®
LAI Antipsychotics for Schizophrenia: Early Intervention Strategies to Improve Outcomes
0.75 credits 5 episodes
- Christoph U. Correll, MD
- Leslie Citrome, MD, MPH
0.75 credits 5 episodes
New and Emerging Treatment Paradigms for SCZ Symptom Management: One Size Does Not Fit All
New and Emerging Treatment Paradigms for SCZ Symptom Management: One Size Does Not Fit All
MinuteCE®
New and Emerging Treatment Paradigms for SCZ Symptom Management: One Size Does Not Fit All
0.75 program credits
- Christoph U. Correll, MD
- Leslie Citrome, MD, MPH
0.75 program credits
Overcoming Clinical Barriers to LAI Administration: Identification of the Negative Stigma Surrounding the Use of Injectable Antipsychotics
Overcoming Clinical Barriers to LAI Administration: Identification of the Negative Stigma Surrounding the Use of Injectable Antipsychotics
MinuteCE®
Overcoming Clinical Barriers to LAI Administration: Identification of the Negative Stigma Surrounding the Use of Injectable Antipsychotics
0.75 program credits
- Christoph U. Correll, MD
0.75 program credits
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
MinuteCE®
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
0.75 program credits
- Kevin Trice, MD
- Michael E. Yurcheshen, MD, FAASM
0.75 program credits
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
MinuteCE®
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
- Kevin Trice, MD
0.75 program credits
Patient Perspective: Living With Insomnia
Patient Perspective: Living With Insomnia
MinuteCE®
Patient Perspective: Living With Insomnia
0.75 program credits
- Kevin Trice, MD
0.75 program credits
Sleep Architecture and Neurotransmitters of Sleep
Sleep Architecture and Neurotransmitters of Sleep
MinuteCE®
Sleep Architecture and Neurotransmitters of Sleep
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
0.75 program credits

2/3